Hours after President Trump said Sunday he had "second thoughts" about escalating the trade war with China, the White House sought to explain his remark because it was...Politicsread more
Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
President Donald Trump said that he would have a major trade deal with U.K. after it leaves the European Union.Politicsread more
Despite Kudlow's expectations, China said on Saturday that it strongly opposes Trump's decision to levy additional tariffs on $550 billion worth of Chinese goods, and warned...Politicsread more
President Donald Trump said Sunday he was not happy after North Korea launched short-range ballistic missiles over the weekend.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
President Donald Trump on Tuesday said Rep. Tom Marino withdrew from consideration for the nation's drug czar, following an investigation that detailed his role in pushing for a law that weakened DEA enforcement during a growing opioid crisis.
A Washington Post and CBS investigation published Sunday described Marino as the "chief advocate" for a drug industry-friendly law that hobbled Drug Enforcement Administration efforts to fight the distribution of prescription narcotics. President Barack Obama signed the bill into law in April 2016.
On Monday, Trump had said he would "make a change" if he felt Marino's nomination hurt his efforts to curb opioid abuse. Trump had tapped Marino, a Pennsylvania Republican and supporter of the president, to lead the Office of National Drug Control Policy.
Manchin, whose state has been hit heavily by the opioid crisis, said in a letter to Trump that Marino's support for the law shows he "either does not fully understand the scope and devastation of this epidemic or ties to the industry overrode those concerns."
In a statement on the Senate floor Monday, Schumer said picking Marino for the position "is like putting the wolf in charge of the hen house."
A spokesman for Marino did not immediately respond to CNBC's request for comment.
More than 33,000 people died in 2015 from prescription opioids, heroin and fentanyl, according to the Centers for Disease Control and Prevention.
The Post report said the law championed by Marino "makes it virtually impossible" for the DEA to freeze suspect narcotic shipments from drug companies. The agency previously had the power to do so and prevent suspicious shipments from reaching the streets, according to the newspaper.
Many members of Congress and the White House did not truly know what the bill would do, said the Post, whose joint expose with CBS was aired on Sunday's "60 Minutes."